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Ultrasound-guided Fine Needle Biopsy of
Splenic Lymphoma
Hsu-Heng Yen, Yang-Yuan Chen and Maw-Soan Soon
While malignant lymphomas are commonly found in the spleen, they do not often
originate there. We describe two lymphoma cases with nonspecific symptoms and
splenic tumors that were discovered fortuitously. Percutaneous fine needle biopsies
were used to provide immunohistochemical classification of the lymphomas. No
complications occurred in either patient. Our experience indicates that fine needle
biopsies are a useful tool to diagnose splenic lymphomas.
(J Med Ultrasound 2003;11:71–5)
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INTRODUCTION
The spleen is a lymphoid organ that is frequently
invaded by malignant lymphomas. However, the
initial presentation of lymphoma as a splenic tumor
is rare and difficult to diagnose. Due to the high
vascularity and relative inaccessibility of the spleen,
most clinicians prefer open splenectomy for tissue
diagnosis. However, with improvements in real-time
sonography, ultrasound-guided fine needle biopsy is
now a safe and easy procedure for sampling splenic
tissue. We diagnosed two cases of splenic lymphoma
using fine needle biopsy and found it to be an
accurate, easy and safe procedure.
CASE 1
A 46-year-old woman with no relevant history visited
our gastroenterology outpatient clinic on November
1, 2002, due to persistent dull abdominal pain over
the left upper quadrant lasting 2 weeks. She did not
have nausea, vomiting, diarrhea, constipation, fever
or weight loss. Physical examination was normal and
no abdominal mass or regional lymphadenopathy
was found. Abdominal sonography demonstrated a
solitary hypoechoic splenic tumor measuring 2.5 cm
in diameter (Fig. 1). Abdominal computed
tomography (CT; Fig. 2) showed a low-density tumor
measuring 2.5 cm in diameter over the posterior
inferior aspect of the spleen, but no abdominal lymph
node enlargement or other tumor.
The hemogram was normal: white blood cell
count 3,800/mm3, hemoglobin 12.2 g/dL, and platelet
count 229,000/mm3. Blood biochemistry revealed
albumin 4.2 g/dL, globulin 3.7 g/dL, blood urea
nitrogen 0.5 mg/dL, creatinine 0.7 mg/dL, aspartate
aminotransferase 23 IU/L, alanine aminotransferase
19 IU/L, total bilirubin 0.55 mg/dL, and lactate
dehydrogenase 491 IU/L.
Diagnostic biopsy was performed using real-time
ultrasound guidance (Toshiba 250; Toshiba, Tokyo,
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Japan) with a 3.5 mHz vector probe and an intercostal
approach. The biopsy needle was a 21 gauge
Angiomed Autovac (Bard, Mississauga, Ontario,
Canada) automated, end-cutting, 2 cm core biopsy
needle. Midazolam (2.5 mg) and meperidine (50 mg)
were given before the biopsy.
After biopsy, the patient lay left side down for
6 hours under close observation. The specimen was
fixed with formalin and processed for pathologic
examination, which revealed a B-cell lymphoma.
Two weeks later, after the patient had gone to
another hospital for a second opinion, the patient
was referred to an oncologist at our hospital. During
this period, several painless, movable, soft lymph
nodes developed over her postauricular area. Excision
biopsy of the lymph nodes also revealed B-cell
lymphoma. Bone marrow was negative for lymphoma
involvement. Stage IIIB B-cell lymphoma was
diagnosed. The patient underwent seven courses
of chemotherapy with the CHOP regimen
(cyclophosphamide, adriamycin, vincristine,
prednisolone). Her disease was stable at the 18-
month follow-up.
CASE 2
A 72-year-old woman with a history of hypertension,
chronic renal insufficiency and congestive heart
failure came to our gastroenterology outpatient clinic
with an upper airway infection in May, 2000. She
had fever, sore throat and sneezing without weight
loss or sweating. On physical examination, the
remarkable finding was a pale conjunctiva. No mass
or regional lymphadenopathy was palpable. Labo-
ratory examination revealed a normal white cell
count (4,300/mm3), normocystic anemia (hemoglobin
7.8 g/dL, mean corpuscular volume 85.6 fL), and
thrombocytopenia (platelet count 72,000/mm3). Other
biochemistry data included creatinine 3.9 mg/dL,
total bilirubin 0.92 mg/dL, aspartate aminotransferase
173 IU/L, alanine aminotransferase 105 IU/L, sodium
132 mmol/L, and potassium 4.3 mmol/L. Abdominal
sonography showed multiple hypoechoic splenic
nodules without any hepatic mass or intra-abdominal
lymphadenopathy.
Chest and abdominal CT showed only splenome-
galy and multiple hypodense splenic tumors (Fig.
3). Diagnostic biopsy was performed via an inter-
costal approach under real-time ultrasound guidance
(Toshiba 250) with a 3.5 mHz vector probe to con-
firm the presence of a lymphoma. A 21 gauge Angio-
med Autovac (Bard) automated, end-cutting, 2 cm core
biopsy needle was used. Midazolam (2.5 mg) and
meperidine (50 mg) were given as premedication.
Hodgkin’s disease was diagnosed (Fig. 4) and the
patient was referred to an oncologist. Eight courses
of chemotherapy with the ABVD regimen
(adriamycin, bleomycin, vinblastine, dacarbazine)
Fig. 1. Abdominal sonography reveals a hypoechoic tumor,
2.5 cm in diameter, in the spleen.
Fig. 2. Contrast-enhanced abdominal computed tomo-
graphy demonstrates a low-density tumor, 2.5 cm in
diameter, in the spleen.
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were given, resulting in complete remission. No
splenic tumors were seen on follow-up abdominal
sonography. The patient had complete remission of
her lymphoma during a 2-year follow-up.
DISCUSSION
Lymphoma is the most frequent malignant splenic
tumor and, at initial diagnosis, the spleen is
involved in as many as 25% of lymphomas. On
the other hand, primary splenic lymphomas are rare
and represent only 1% to 2% of all lymphoma cases.
The clinical symptoms include fever, fatigue,
weight loss, dull left lower quadrant pain, and
splenomegaly [2]. Fatal splenic rupture caused by
a lymphoma has also been reported [3]. On
sonography, splenic lymphoma appears as diffusely
homogeneous spleen enlargement, miliary lesions
less than 5 mm in diameter, multiple tumors larger
than 5 mm, or as a single tumor [4, 5]. Splenic
involvement tends to be hypoechoic and never cystic
[5]. High-grade non-Hodgkin’s lymphoma usually
exhibits larger focal lesions while low-grade non-
Hodgkin’s lymphoma usually has multiple small
lesions or diffuse splenic involvement. In Hodgkin’s
lymphoma, both focal and diffuse patterns are seen
(43% vs 57%). Therefore, sonography may be helpful
in following existing lymphomas but is not sufficient
to make a diagnosis.
In our two cases, non-invasive imaging studies
failed to show the nature of the splenic tumor. No
extrasplenic involvement at presentation made tissue
sampling more difficult. Observation or diagnostic
splenectomy are the traditional choices. However,
we decided to arrange for splenic core biopsies. A normal
coagulation profile and platelet count (> 70,000/mm3)
are mandatory before biopsy. A 21 gauge biopsy
needle is used under ultrasound guidance. No
complication occurred and only outpatient observation
for 6 hours with a reminder card was required. Both
tissue samples were adequate for histologic diagnosis
and immunohistochemical subclassification of the
lymphoma.
There are five methods to sample splenic tissue
for pathologic examination. A surgical approach
includes open biopsy, open splenectomy and
laparoscopic splenectomy. Less invasive approaches
include percutaneous fine needle aspiration biopsy
and core biopsy under ultrasonic guidance.
Fine needle aspiration biopsy of the spleen was
first reported in 1916 for the diagnosis of
leishmaniasis. In the 1970s, Soderstrom reported that
more than 1,000 patients underwent splenic aspiration
biopsy without significant complications [6]. This
procedure can be used to confirm the diagnosis of
systemic diseases, such as lymphoma, sarcoidosis
[7], amyloidosis, storage diseases, infectious diseases
and neoplastic diseases [8]. Unfortunately, most
Fig. 3. Contrast-enhanced abdominal computed tomo-
graphy demonstrates splenomegaly and multiple low-
density tumors in the spleen.
Fig. 4. Histopathologic examination of a biopsy specimen
from Case 2 reveals the characteristic Reed-Sternberg
cells of Hodgkin’s disease (hematoxylin & eosin, = 300).
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clinicians still regard it as a dangerous diagnostic
procedure. Splenectomy has become the preferred
procedure for diagnosis and staging of lymphoma
and other splenic diseases.
Recently, fine needle aspiration biopsy has been
used more frequently because of improvements in
the quality of ultrasound. Fine needle aspiration
biopsy has been used to diagnose lymphoma with
an accuracy rate of 64% to 94% [9, 10]. With
splenic aspiration biopsy, the overall sensitivity ranges
from 68% to 84% [8, 11–13]. The complication rate
was low and only one of 140 patients required
surgical splenectomy due to internal bleeding [11].
The authors concluded that splenic aspiration biopsy
is a safe and easy procedure and sepsis from
splenectomy can be avoided.
Less information is available on fine needle core
biopsy. This preserves tissue architecture and leaves
the tissue element intact for pathologic examination.
A multicenter study involving 398 patients compared
aspiration biopsy and core biopsy [14]. The diagnostic
accuracy was similar when the underlying diseases
were granulomatosis, tuberculosis and metastasis.
However, accuracy was different (68.5% vs 90.9%)
when the underlying disease was lymphoma, caused
by the high number of poor samples from aspiration
biopsy. Therefore, when diagnosing lymphoma, both
aspiration biopsy and core biopsy can be used to
increase the overall yield.
The complication rate of core biopsy was similar
to that of aspiration biopsy and dependent on the
size of the biopsy needle. In Lindgren et al's study
[15], a high complication rate of 13% was reported
when a large (14 gauge) biopsy needle was used.
However, other studies using 18 to 21 gauge biopsy
needles found complication rates to be lower than
1% [12, 14–16]. Similar results were obtained in
children. In Muraca et al’s study [17], 30 children
were examined under general anesthesia (70%) or
conscious sedation (30%). In this series, the biopsy
needles varied from 18 to 21 gauge. The diagnosis
rate was 83% with no complications. A normal
coagulation profile and a platelet count of more than
70,000/mm3 before the procedure were required to
avoid bleeding.
In these studies, two or more passes of the biopsy
needle were used to sample the diffuse splenic lesion,
and this approach did not increase the risk of
complications. Therefore, in both children and adults,
fine needle biopsy was safe and accurate. However,
one laparoscopic splenectomy study reported a
diagnosis rate of 71%, with a complication rate as
high as 28% [18].
According to previous results and our findings,
fine needle biopsy of the spleen provides similar
diagnostic accuracy to surgical splenectomy, with a
lower complication rate. Fine needle biopsy of the
spleen is especially helpful for staging and diagnosing
lymphoma since an accurate diagnosis usually affects
the treatment plan and improves prognosis.
In conclusion, this limited experience shows that
percutaneous fine needle biopsy of the spleen might
be an accurate, easy and safe diagnostic procedure.
It can provide a better tissue sample for histologic
and immunohistochemical classification of
lymphomas than aspiration biopsy. Unnecessary
splenectomy can be avoided and hospital costs
reduced.
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